The role of genotype/phenotype at apurinic/apyrimidinic endonuclease Rs1130409 in renal cell carcinoma

doi:10.4103/CJP.CJP_72_19

中山醫學大學機構典藏 CSMUIR > 中山醫學大學研究成果 > 期刊論文 > Item 310902500/24756

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24756

Title:	The role of genotype/phenotype at apurinic/apyrimidinic endonuclease Rs1130409 in renal cell carcinoma
Authors:	Liao, CH;Chang, WS;Liao, JM;Wu, HC;Shen, TC;Yang, JS;Tsai, FJ;Tsai, CW;Yu, CC;Bau, D
Keywords:	Apurinic;apyrimidinic endonuclease;DNA repair;polymorphism;renal cell carcinoma
Date:	2020
Issue Date:	2022-08-09T08:07:29Z (UTC)
Publisher:	WOLTERS KLUWER MEDKNOW PUBLICATIONS
ISSN:	0304-4920
Abstract:	The DNA repair capacity plays a critical role in maintaining the genomic stability and gatekeeping for individual cancer risk. In this study, we aim at evaluation the role of the Asp148Glu (rs1130409) variant at apurinic/apyrimidinic endonuclease (APE) gene in renal cell carcinoma (RCC) risk and the contribution of different genotypes to its transcriptional mRNA levels. In the case-control study, 92 RCC patients and 580 cancer-free patients matched by age and gender were recruited. The apurinic/APE genotyping work was conducted with typical restriction fragment length polymorphism methodology after polymerase chain reaction. At the meanwhile, thirty renal tissue samples with variant genotypes were examined for their apurinic/APE mRNA and protein expressions by real-time quantitative reverse transcription method and Western blotting. The results showed that compared with the wild-type TT genotype, the people with TG and GG genotypes of apurinic/APE Asp148Glu had 0.88- and 1.09-fold risk of RCC, respectively. We have also examined the in vivo transcriptional (RNA) and translational (protein) levels with renal tissues of various apurinic/APE Asp148Glu genotypes, revealing that the apurinic/APE mRNA and protein were of similar levels among people of TT, TG, or GG genotypes. There was no joint gene-environment effect of apurinic/APE Asp148Glu genotype and smoking habit on RCC risk. The evidence indicated that apurinic/APE Asp148Glu genotypic variants did not alter its mRNA and protein expression among RCC patients. The genotype of apurinic/APE Asp148Glu may not serve as a proper predictive marker for RCC risk in Taiwan.
URI:	http://dx.doi.org/10.4103/CJP.CJP_72_19 https://www.webofscience.com/wos/woscc/full-record/WOS:000515357200007 https://ir.csmu.edu.tw:8080/handle/310902500/24756
Relation:	CHINESE JOURNAL OF PHYSIOLOGY ,2020 ,v63 ,issue 1 ,p43-49
Appears in Collections:	[中山醫學大學研究成果] 期刊論文

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	156	View/Open

Loading...